Today at 16:01
Photo: APF
French company Carmat announced the first commercial implantation of its Aeson artificial heart.
UA reports this with reference to Ukrinform.
A patient in Italy received an artificial heart. The transplant operation was done in Naples.
According to the press service of Carmat, the operation marks the first sale of an artificial heart since 2008, since the company’s inception. This agreement made the way for further commercial development of the enterprise. The company’s shares on the stock market rose after the announcement of the event.
The sale of the Aeson prosthesis in Europe has been allowed since December 2020. Until now, no Aeson heart has been used outside of clinical trials. The operation was paid for by the regional health care system, and its cost was EUR 150,000.
